Cell-free DNA levels in plasma of patients with non-small-cell lung cancer and inflammatory lung disease

BACKGROUND: The analysis of plasma cell-free DNA (cfDNA) is expected to provide useful biomarkers for early diagnosis of non-small-cell lung cancer (NSCLC). However, it remains unclear whether the intense release of cfDNA into the bloodstream of NSCLC patients results from malignancy or chronic infl...

Descripción completa

Detalles Bibliográficos
Autores principales: Szpechcinski, A, Chorostowska-Wynimko, J, Struniawski, R, Kupis, W, Rudzinski, P, Langfort, R, Puscinska, E, Bielen, P, Sliwinski, P, Orlowski, T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522634/
https://www.ncbi.nlm.nih.gov/pubmed/26125447
http://dx.doi.org/10.1038/bjc.2015.225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522634/
https://www.ncbi.nlm.nih.gov/pubmed/26125447
http://dx.doi.org/10.1038/bjc.2015.225

Ejemplares similares